Ligand Pharmaceuticals Other Income and Expenses (Quarterly) Analysis

Ligand Pharmaceuticals, Inc. (LGND)

204.77 +2.22 (+1.10%) USD | NASDAQ | Mar 03, 16:00

204.42 -0.35 (-0.17%) Pre-Market: 20:00

View Other Income and Expenses (Quarterly) for LGND.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Income and Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Income and Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Income and Expenses (Quarterly) Benchmarks

Start Trial